These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Wijffels MC; Dorland R; Mast F; Allessie MA Circulation; 2000 Jul; 102(2):260-7. PubMed ID: 10889140 [TBL] [Abstract][Full Text] [Related]
24. The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: effects on cardiac function and drug clearance. Holtzman JL; Finley D; Mottonen L; Berry DA; Ekholm BP; Kvam DC; McQuinn RL; Miller AM Clin Pharmacol Ther; 1989 Jul; 46(1):26-32. PubMed ID: 2501057 [TBL] [Abstract][Full Text] [Related]
25. Development of telemetry system in the common marmoset--cardiovascular effects of astemizole and nicardipine. Horii I; Kito G; Hamada T; Jikuzono T; Kobayashi K; Hashimoto K J Toxicol Sci; 2002 May; 27(2):123-30. PubMed ID: 12058448 [TBL] [Abstract][Full Text] [Related]
26. Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole. Yamamoto K; Tamura T; Imai R; Yamamoto M Toxicol Sci; 2001 Mar; 60(1):165-76. PubMed ID: 11222883 [TBL] [Abstract][Full Text] [Related]
27. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model. Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000 [TBL] [Abstract][Full Text] [Related]
28. Dynamic all-optical drug screening on cardiac voltage-gated ion channels. Streit J; Kleinlogel S Sci Rep; 2018 Jan; 8(1):1153. PubMed ID: 29348631 [TBL] [Abstract][Full Text] [Related]
29. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease. Sarubbi B; Ducceschi V; Briglia N; Mayer MS; Santangelo L; Iacono A Int J Cardiol; 1998 Sep; 66(2):157-64. PubMed ID: 9829329 [TBL] [Abstract][Full Text] [Related]
30. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study. Komatsu R; Honda M; Holzgrefe HH; Kubo J; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M J Pharmacol Toxicol Methods; 2010; 61(3):271-6. PubMed ID: 20097298 [TBL] [Abstract][Full Text] [Related]
31. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation. Lu HR; Remeysen P; De Clerck F J Cardiovasc Pharmacol; 2000 Dec; 36(6):728-36. PubMed ID: 11117372 [TBL] [Abstract][Full Text] [Related]
32. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes. Hey JA; del Prado M; Kreutner W; Egan RW Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic-pharmacodynamic analysis of the electrocardiographic effects of terfenadine and quinidine in rats. Ohtani H; Hanada E; Yamamoto K; Sawada Y; Iga T Biol Pharm Bull; 1996 Sep; 19(9):1189-96. PubMed ID: 8889039 [TBL] [Abstract][Full Text] [Related]
34. Predicting QRS and PR interval prolongations in humans using nonclinical data. Bergenholm L; Parkinson J; Mettetal J; Evans ND; Chappell MJ; Collins T Br J Pharmacol; 2017 Oct; 174(19):3268-3283. PubMed ID: 28675424 [TBL] [Abstract][Full Text] [Related]
35. Changes in global electrical heterogeneity associated with dofetilide, quinidine, ranolazine, and verapamil. Stabenau HF; Shen C; Tereshchenko LG; Waks JW Heart Rhythm; 2020 Mar; 17(3):460-467. PubMed ID: 31539628 [TBL] [Abstract][Full Text] [Related]
36. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers. Goineau S; Castagné V J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391 [TBL] [Abstract][Full Text] [Related]
37. Effects of the T-type Ca(2+) channel blocker mibefradil on repolarization of guinea pig, rabbit, dog, monkey, and human cardiac tissue. Bénardeau A; Weissenburger J; Hondeghem L; Ertel EA J Pharmacol Exp Ther; 2000 Feb; 292(2):561-75. PubMed ID: 10640293 [TBL] [Abstract][Full Text] [Related]
38. Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil. Johannesen L; Vicente J; Mason JW; Sanabria C; Waite-Labott K; Hong M; Guo P; Lin J; Sørensen JS; Galeotti L; Florian J; Ugander M; Stockbridge N; Strauss DG Clin Pharmacol Ther; 2014 Nov; 96(5):549-58. PubMed ID: 25054430 [TBL] [Abstract][Full Text] [Related]
39. Measurements of blood pressure and electrocardiogram in conscious freely moving guineapigs: a model for screening QT interval prolongation effects. Hess P; Rey M; Wanner D; Steiner B; Clozel M Lab Anim; 2007 Oct; 41(4):470-80. PubMed ID: 17988441 [TBL] [Abstract][Full Text] [Related]
40. Effects of Na+ channel blockers on the restitution of refractory period, conduction time, and excitation wavelength in perfused guinea-pig heart. Osadchii OE PLoS One; 2017; 12(2):e0172683. PubMed ID: 28231318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]